About Infervision
Infervision Medical Technology Co., Ltd. (推想医疗科技股份有限公司) was established in 2016 with the vision of "improving life and health through AI." The company has positioned itself as an international leader in hospital-wide AI solutions. Infervision employs a comprehensive "horizontal and vertical" strategic approach combined with international expansion. Horizontally, the company covers multiple disease areas including cancer, infectious diseases, cardiovascular disease, cerebrovascular disease, and trauma. Vertically, it follows the patient care pathway from disease screening and diagnosis through intervention and treatment to patient health management and medical research. The company provides advanced integrated smart healthcare services to governments, medical institutions, physicians, and patients. Infervision's products utilize deep learning technology and convolutional neural network models that mimic human cognitive processes. The company's solutions have obtained regulatory clearances from China's NMPA, US FDA, EU CE, UK UKCA, and Japan's PMDA, representing access to five major global markets. Products are deployed in over 1,000 healthcare institutions across more than 30 countries worldwide. The company has accumulated over 390 patents (granted and pending), published more than 350 SCI core papers, and maintains a strong research collaboration network with leading academic medical centers.
Mission & Story
Mission
AI改善生命健康 (AI to improve life and health)
Clinical Focus
Medical conditions and clinical areas addressed by Infervision.
Who It Serves
Milestones & Awards
Recent Milestones
WHO recommendation for InferRead DR Chest tuberculosis screening (2025); CE MDR and UKCA certification for surgical planning AI (2025); NMPA approval for bone fracture X-ray triage software (2025); Nature Communications publication on AI 3D reconstruction (2025); npj Digital Medicine publication on virtual thin-slice CT (2025)
Awards & Recognition
WHO official recommendation for tuberculosis screening AI (only Chinese AI product recommended); Beijing Medical Science and Technology Award nomination (2024); Multiple publications in Nature family journals and IEEE TMI
Key Partnerships
Company Details
- Founded
- 2016
- Headquarters
- Beijing, China
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.